Patton Albertson Miller Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-8,974
| Closed | -$488K | – | 218 |
|
2022
Q2 | $488K | Sell |
8,974
-1,300
| -13% | -$70.7K | 0.1% | 162 |
|
2022
Q1 | $559K | Buy |
10,274
+120
| +1% | +$6.53K | 0.1% | 166 |
|
2021
Q4 | $560K | Buy |
10,154
+436
| +4% | +$24K | 0.09% | 175 |
|
2021
Q3 | $464K | Buy |
9,718
+460
| +5% | +$22K | 0.09% | 175 |
|
2021
Q2 | $461K | Sell |
9,258
-1,420
| -13% | -$70.7K | 0.11% | 147 |
|
2021
Q1 | $476K | Sell |
10,678
-35
| -0.3% | -$1.56K | 0.12% | 148 |
|
2020
Q4 | $477K | Sell |
10,713
-2,973
| -22% | -$132K | 0.11% | 148 |
|
2020
Q3 | $644K | Sell |
13,686
-1,636
| -11% | -$77K | 0.18% | 120 |
|
2020
Q2 | $781K | Sell |
15,322
-61
| -0.4% | -$3.11K | 0.23% | 114 |
|
2020
Q1 | $729K | Sell |
15,383
-149
| -1% | -$7.06K | 0.25% | 111 |
|
2019
Q4 | $912K | Buy |
15,532
+154
| +1% | +$9.04K | 0.24% | 114 |
|
2019
Q3 | $820K | Sell |
15,378
-819
| -5% | -$43.7K | 0.23% | 123 |
|
2019
Q2 | $819K | Buy |
+16,197
| New | +$819K | 0.24% | 120 |
|
2018
Q4 | – | Sell |
-660
| Closed | -$32K | – | 181 |
|
2018
Q3 | $32K | Buy |
+660
| New | +$32K | 0.02% | 197 |
|